Evidence map›Paper›PMID 34215282›Full record

ArticleCost effectiveness and resource allocation : C/E2021

Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact.

Robyn Millar, Alec Morton, Maria Vittoria Bufali, Sven Engels, Saudamini Vishwanath Dabak, Wanrudee Isaranuwatchai, Kalipso Chalkidou, Yot Teerawattananon

Open access · goldAbstract read
In one paragraph

Article in Cost effectiveness and resource allocation : C/E, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Innovating HTA: a call for capacity building and standardization.International journal of technology assessment in health care · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. A situational and stakeholder analysis of health technology assessment in Zimbabwe.International journal of technology assessment in health care · 2024
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 5 countries.

Robyn MillarDepartment of Management Science, University of Strathclyde Business School, Sir William Duncan Building (Level 7), 130 Rottenrow, Glasgow, G4 0GE, UK. robyn.millar@strath.ac.uk.ORCID http://orcid.org/0000-0002-4152-3380
Alec MortonDepartment of Management Science, University of Strathclyde Business School, Sir William Duncan Building (Level 7), 130 Rottenrow, Glasgow, G4 0GE, UK.
Maria Vittoria BufaliDepartment of Management Science, University of Strathclyde Business School, Sir William Duncan Building (Level 7), 130 Rottenrow, Glasgow, G4 0GE, UK.
Sven EngelsHealth Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand.
Saudamini Vishwanath DabakHealth Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand.
Wanrudee IsaranuwatchaiHealth Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand.
Kalipso ChalkidouGlobal Health at Imperial College London, London, UK.
Yot TeerawattananonHealth Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand.
Ministry of Public Health · THUniversity of Strathclyde · GBCenter for Global Development · US

Funding

Bill and Melinda Gates Foundation OPP1134345Thailand Research Fund RTA5980011
6 · The paper itself

Abstract

backgroundHealth technology assessment (HTA) agencies have an important role to play in managing the rising demands on health systems. However, creating and running such agencies potentially diverts resources from frontline services. A large number of studies address the question of 'what is the impact of HTA?'. Several points of heterogeneity in this literature include: purpose of the study, definition of HTA, definition of impact, and scope and rigour of evaluations. Our study seeks to address several limitations in this literature. This study aims to explore the mechanisms of impact of an HTA agency. In doing so, we consider HTA as an institution rather than a knowledge product to build an impact evaluation framework from an international, multi-stakeholder and multi-dimensional perspective.

methodsWe conducted 9 key informant interviews with experts from the international HTA community. We addressed several questions, informed by existing frameworks of impact within the literature, to understand their perspectives on the mechanisms of impact of an HTA agency. We analyse data using logic modelling and impact mapping, as tools to understand and visualise mechanisms of change.

findingsOur impact mapping highlights several distinct, but not necessarily mutually exclusive, mechanisms through which the overall impact of an HTA agency is achieved. These are: the effective conduct of HTA studies; effective use of HTA in agenda-setting and policy formulation processes; effective engagement and external communications; good institutional reputation and fit within the healthcare and policy-making system; effective use of HTA as a tool for the negotiation of health technology prices; and the effective implementation of policy change regarding health technologies. We also identify indicators of these effects.

conclusionsOur findings and resulting evaluation framework complement and add to existing literature by offering a new perspective on the mechanisms by which HTA agencies generate impact. This new perspective considers HTA as an institution rather than a knowledge product, is international, multi-dimensional, and includes multi-stakeholder views. We hope the analysis will be useful to countries interested in managing HTA performance.

Indexed as

EvaluationHealth technology assessmentHealth technology assessment agency

Identifiers

PMID34215282
PMCPMC8252304
OpenAlexW3174615012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.